Disease Exacerbation after the Cessation of Fingolimod Treatment in Japanese Patients with Multiple Sclerosis

OBJECTIVE: In Japan, following the launch of dimethyl fumarate (DMF) after fingolimod as a disease-modifying drug in multiple sclerosis (MS), some patients switched from fingolimod to DMF. The aim of this study was to determine the follow-up status of MS patients who switched to DMF after fingolimod...

Descripción completa

Detalles Bibliográficos
Autores principales: Sato, Kazunori, Niino, Masaaki, Kawashima, Atsushi, Yamada, Moemi, Miyazaki, Yusei, Fukazawa, Toshiyuki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Japanese Society of Internal Medicine 2018
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6191590/
https://www.ncbi.nlm.nih.gov/pubmed/29709955
http://dx.doi.org/10.2169/internalmedicine.0793-18

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6191590/
https://www.ncbi.nlm.nih.gov/pubmed/29709955
http://dx.doi.org/10.2169/internalmedicine.0793-18

Ejemplares similares